chronic treatment with a pure antiandrogen or a potent lhrh agonist ( lhrh-a ) alone has no significant effect on egf receptor concentration in prostatic tissue , although , secondary to a reduction in prostatic weight , total prostatic egf binding capacity is reduced following antiandrogen or lhrh-a treatment .
C1514521
prostatic tissue
C0033572
prostatic